Historical shareholding details of Wellington Global Health Care Equity holdings in Xenon Pharmaceuticals Inc (XENE)

Monthly changes of Wellington Global Health Care Equity shareholding in Xenon Pharmaceuticals Inc over the previous months

Month Name Total no. shares held Percent Holding
Jul 31, 2025 Wellington Global Health Care Equity 266,530 0.35%
Jun 30, 2025 Wellington Global Health Care Equity 241,747 0.31%
May 31, 2025 Wellington Global Health Care Equity 241,747 0.32%
Apr 30, 2025 Wellington Global Health Care Equity 241,747 0.32%
Mar 31, 2025 Wellington Global Health Care Equity 287,868 0.38%
Feb 28, 2025 Wellington Global Health Care Equity 287,868 0.38%
Jan 31, 2025 Wellington Global Health Care Equity 287,868 0.38%
Dec 31, 2024 Wellington Global Health Care Equity 262,287 0.34%
Nov 30, 2024 Wellington Global Health Care Equity 294,373 0.39%
Oct 31, 2024 Wellington Global Health Care Equity 303,490 0.40%
Sep 30, 2024 Wellington Global Health Care Equity 303,490 0.40%
Aug 31, 2024 Wellington Global Health Care Equity 305,325 0.40%
Jul 31, 2024 Wellington Global Health Care Equity 337,781 0.45%
Jun 30, 2024 Wellington Global Health Care Equity 342,901 0.45%
May 31, 2024 Wellington Global Health Care Equity 361,086 0.48%
Apr 30, 2024 Wellington Global Health Care Equity 429,956 0.57%
Mar 31, 2024 Wellington Global Health Care Equity 441,191 0.58%
Feb 29, 2024 Wellington Global Health Care Equity 449,506 0.60%
Dec 31, 2023 Wellington Global Health Care Equity 524,761 0.70%
Nov 30, 2023 Wellington Global Health Care Equity 452,631 0.60%
Oct 31, 2023 Wellington Global Health Care Equity 350,661 0.54%
Sep 30, 2023 Wellington Global Health Care Equity 245,101 0.38%
Aug 31, 2023 Wellington Global Health Care Equity 137,761 0.21%
Jul 31, 2023 Wellington Global Health Care Equity 142,701 0.22%
Jun 30, 2023 Wellington Global Health Care Equity 147,151 0.23%
May 31, 2023 Wellington Global Health Care Equity 149,558 0.24%
Apr 30, 2023 Wellington Global Health Care Equity 150,713 0.24%

View all ownership details of Xenon Pharmaceuticals Inc